May Measurement Month 2022: results from the global blood pressure screening campaign
datacite.rights | http://purl.org/coar/access_right/c_abf2 | |
dc.contributor.author | Beaney, Thomas | |
dc.contributor.author | Keziah Kerr, Gabriele | |
dc.contributor.author | Kiru, Gaia | |
dc.contributor.author | McArdle, Harsha | |
dc.contributor.author | Schlaich, Markus | |
dc.contributor.author | Schutte, Aletta E. | |
dc.contributor.author | Stergiou, George S. | |
dc.contributor.author | Ji-guang, Wang | |
dc.contributor.author | Marin, Marcos J. | |
dc.contributor.author | Henandez-Hernandez, Rafael | |
dc.contributor.author | F. Diaz, Alejandro Bimbo | |
dc.contributor.author | Alcocer, Luis | |
dc.contributor.author | Lopez-Jaramillo, Patricio | |
dc.contributor.author | Poulter, Neil | |
dc.contributor.author | Lopez-Lopez, José P. | |
dc.contributor.author | Otero, Odont Johanna | |
dc.contributor.author | Zulma, Urbina | |
dc.contributor.author | Sanchez-Vallejo, Gregorio | |
dc.contributor.author | Narváez, Claudia | |
dc.contributor.author | Camacho, Paul A. | |
dc.contributor.author | Urina-Triana, Miguel | |
dc.contributor.author | Quintero, Adalberto | |
dc.contributor.author | Aroca, Gustavo | |
dc.contributor.author | Campos, Alfonso | |
dc.contributor.author | Arcos, Edgar | |
dc.contributor.author | Pérez-Mayorga, Maritza | |
dc.contributor.author | Mosquera, Walter | |
dc.contributor.author | García-Ortiz, Luis H. | |
dc.date.accessioned | 2024-12-16T14:55:19Z | |
dc.date.available | 2024-12-16T14:55:19Z | |
dc.date.issued | 2024 | |
dc.description.abstract | Introduction Elevated blood pressure (BP) is the major contributor to mortality and disease burden worldwide. May Measurement Month (MMM) is a global BP screening campaign, which aims to raise awareness of BP measurement and provide evidence to inform and influence related health policy. Methods This cross-sectional survey included individuals aged≥18 years recruited through opportunistic sampling at sites in 60 countries during MMM 2022. Each participant had three sitting BP measurements and a questionnaire was completed including demographics, comorbidities and lifestyle factors. Hypertension was defined as a systolic BP≥140 mm Hg and/or a diastolic BP≥90 mm Hg (average of the second and third readings) or taking antihypertensive medication. Multiple imputation was used to estimate BP readings where any participant’s BP readings were missing. Linear mixed effects models were used to identify associations between participant characteristics and systolic or diastolic BP. Results Of the 715 518 participants surveyed (excluding 50 200 self-measured home BP screenees recruited via the ZOE Health Study app), 257 421 (36.0%) were identified as hypertensive, of whom 57.6% were aware and 49.3% were on antihypertensive medication. Of all participants with hypertension, 26.1% were controlled to <140/90 mm Hg and 12.0% to <130/80 mm Hg. Of those taking antihypertensive medication, 52.7% were taking only one drug class, 52.9% were controlled to <140/90 mm Hg and 24.4% to 130/80 mm Hg. In total, 190 314 (26.6% of total surveyed, 73.9% of hypertensives) participants screened were found to have untreated or inadequately treated hypertension. Only 27.6% of treated hypertensive participants were taking a statin. Substantial coexistence of diabetes, overweight and hypertension was apparent among participants. | eng |
dc.format.mimetype | ||
dc.identifier.citation | Beaney T, Kerr GK, Kiru G, et al. May Measurement Month 2022: results from the global blood pressure screening campaign. BMJ Glob Health 2024;9:e016557. doi:10.1136/bmjgh-2024-016557 | eng |
dc.identifier.doi | https:// doi. org/ 10. 1136/bmjgh- 2024- 016557 | |
dc.identifier.issn | 20597908 (Electrónico) | |
dc.identifier.uri | https://hdl.handle.net/20.500.12442/16065 | |
dc.identifier.url | https://gh.bmj.com/content/9/12/e016557 | |
dc.language.iso | eng | |
dc.publisher | BMJ | spa |
dc.rights | Attribution-NonCommercial-NoDerivs 3.0 United States | eng |
dc.rights.accessrights | info:eu-repo/semantics/openAccess | |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/3.0/us/ | |
dc.source | BMJ Glob Health | eng |
dc.source | Vol. 9, No. 12 (2024) | spa |
dc.subject.keywords | Blood pressure | eng |
dc.subject.keywords | COVID-19 | eng |
dc.subject.keywords | BP detection | eng |
dc.title | May Measurement Month 2022: results from the global blood pressure screening campaign | eng |
dc.type.driver | info:eu-repo/semantics/article | |
dc.type.spa | Artículo científico | |
dcterms.references | Poulter N, Prabhakaran D, Hypertension CM. Lancet 2015;386:801–12. | eng |
dcterms.references | GBD 2019 Risk Factors Collaborators. Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet 2020;396:1223–49. | eng |
dcterms.references | Zhou B, Danaei G, Stevens GA, et al. Long-term and recent trends in hypertension awareness, treatment, and control in 12 high-income countries: an analysis of 123 nationally representative surveys. The Lancet 2019;394:639–51. | eng |
dcterms.references | Geldsetzer P, Manne-Goehler J, Marcus M-E, et al. The state of hypertension care in 44 low-income and middle-income countries: a cross-sectional study of nationally representative individual-level data from 1·1 million adults. The Lancet 2019;394:652–62. | eng |
dcterms.references | Poulter NR, Lackland DT. May Measurement Month: a global blood pressure screening campaign. The Lancet 2017;389:1678–80. | eng |
dcterms.references | Poulter NR, Borghi C, Castillo RR, et al. May Measurement Month 2017: Results of 39 national blood pressure screening programmes. Eur Heart J Suppl 2019;21:D1–4. | eng |
dcterms.references | Beaney T, Schutte AE, Tomaszewski M, et al. May Measurement Month 2017: an analysis of blood pressure screening results worldwide. Lancet Glob Health 2018;6:e736–43. | eng |
dcterms.references | Beaney T, Burrell LM, Castillo RR, et al. May Measurement Month 2018: a pragmatic global screening campaign to raise awareness of blood pressure by the International Society of Hypertension. Eur Heart J 2019;40:2006–17. | eng |
dcterms.references | Beaney T, Schutte AE, Stergiou GS, et al. May Measurement Month 2019: The Global Blood Pressure Screening Campaign of the International Society of Hypertension. Hypertension 2020;76:333–41. | eng |
dcterms.references | Beaney T, Wang W, Schlaich MP, et al. Global blood pressure screening during the COVID-19 pandemic: results from the May Measurement Month 2021 campaign. J Hypertens 2023;41:1446–55. | eng |
dcterms.references | Dale CE, Takhar R, Carragher R, et al. The impact of the COVID-19 pandemic on cardiovascular disease prevention and management. Nat Med 2023;29:219–25. | eng |
dcterms.references | Gotanda H, Liyanage-Don N, Moran AE, et al. Changes in Blood Pressure Outcomes Among Hypertensive Individuals During the COVID-19 Pandemic: A Time Series Analysis in Three US Healthcare Organizations. Hypertension 2022;79:2733–42. | eng |
dcterms.references | Jeemon P, Séverin T, Amodeo C, et al. World Heart Federation Roadmap for Hypertension - A 2021 Update. Glob Heart 2021;16:63. | eng |
dcterms.references | Mancia G, Kreutz R, Brunström M, et al. 2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension: Endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA). J Hypertens 2023;41:1874–2071. | eng |
dcterms.references | Unger T, Borghi C, Charchar F, et al. 2020 International Society of Hypertension Global Hypertension Practice Guidelines. Hypertension 2020;75:1334–57. | eng |
dcterms.references | Williams B, Mancia G, Spiering W, et al. ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH). Eur Heart J 2018;39:3021–104. | eng |
dcterms.references | R Core Team. R: a language and environment for statistical computing. 2023. | eng |
dcterms.references | StataCorp. Stata statistical software: release 18. 2023. | eng |
dcterms.references | UN Statistics Division. Standard country or area codes for statistical use (M49). 2023. | eng |
dcterms.references | The World Bank. World bank country and lending groups. 2023. | eng |
dcterms.references | Surveillance Epidemiology and End Results (SEER) Program. Standard populations - single ages. | eng |
dcterms.references | Seaman SR, Bartlett JW, White IR. Multiple imputation of missing covariates with non-linear effects and interactions: an evaluation of statistical methods. BMC Med Res Methodol 2012;12:46. | eng |
dcterms.references | Lin Q, Ye T, Ye P, et al. Hypertension in stroke survivors and associations with national premature stroke mortality: data for 2·5 million participants from multinational screening campaigns. Lancet Glob Health 2022;10:e1141–9. | eng |
dcterms.references | Janssen C, Wang W, Schlaich M, et al. S-53- 4: HYPERTENSION AND ITS ASSOCIATIONS WITH MULTIMORBIDITY: AN ANALYSIS OF 4 MILLION PARTICIPANTS FROM MAY MEASUREMENT MONTH 2017–2019. J Hypertens (Los Angel) 2023;41:e117–8. | eng |
dcterms.references | Kerr GK, Schlaich M, Schutte AE, et al. PS-P04- 7: ALERTING REACTION OF BLOOD PRESSURE AND AGE: MAY MEASUREMENT MONTH 2019. J Hypertens (Los Angel) 2023;41:e247–8. | eng |
dcterms.references | Kerr GK, Schlaich M, Schutte AE, et al. PS-P04- 8: COMPARISON OF INDICES OF WITHIN-VISIT BLOOD PRESSURE VARIABILITY IN MAY MEASUREMENT MONTH 2019. J Hypertens (Los Angel) 2023;41:e248. | eng |
dcterms.references | World Health Organisation. Post COVID-19 condition (long COVID). 2022. | eng |
dcterms.references | Matsumoto C, Shibata S, Kishi T, et al. Long COVID and hypertension-related disorders: a report from the Japanese Society of Hypertension Project Team on COVID-19. Hypertens Res 2023;46:601–19. | eng |
dcterms.references | Sedgwick P. Convenience sampling. BMJ 2013;347:f6304. | eng |
dcterms.references | Chen S, Sudharsanan N, Huang F, et al. Impact of community based screening for hypertension on blood pressure after two years: regression discontinuity analysis in a national cohort of older adults in China. BMJ 2019;366. | eng |
oaire.version | info:eu-repo/semantics/publishedVersion |
Archivos
Bloque de licencias
1 - 1 de 1
No hay miniatura disponible
- Nombre:
- license.txt
- Tamaño:
- 381 B
- Formato:
- Item-specific license agreed upon to submission
- Descripción: